Protein Engineering Market by Technology (Rational Design, Irrational Design), Protein Type (Monoclonal Antibodies, Insulin) – Global Forecast to 2024
Protein Engineering Market report provides analysis of top players in all regions with industry size, growth, technology, market insights, demand, trend, key statistics and industry forecasts to 2024.
The “Protein Engineering Market” report presents an in-depth assessment of the Protein Engineering including enabling technologies, key trends, market drivers, challenges, deployment case studies, standardization, opportunities, future roadmap, value chain, Top key player profiles and strategies. The report also presents market size forecasts from 2019 till 2024.
The Global Protein Engineering Market is estimated to grow from US$ 2.2 Billion in 2019 to US$ 3.9 Billion by 2024, at a CAGR of 12.4% during the forecast period. This report spread across 146 Pages, Profiling 20 Companies and Supported with 132 Tables and 32 figures is now available in this research.
Top Companies profiled in the Protein Engineering Market:
- Thermo Fisher Scientific (US)
- Bio-Rad Laboratories (US)
- Agilent Technologies (US)
- Waters Corporation (US)
- Danaher Corporation (US)
“Instruments segment to account for the largest share of the protein engineering market, by product and service, in 2019”
Based on product and service, the protein engineering market is segmented into instruments, consumables, and softwareand services. Instruments formed the largest product segment in this market in 2019 due to technological advancements in mass spectrometry and X-ray crystallography systems and their ability to integrate with other technologies.
Get 20% Discount on Updated report @ https://www.reportsnreports.com/contacts/discount.aspx?name=231673
“Monoclonal antibodies segment to grow at the highest CAGR in the protein engineering market, by protein type, in 2019”
Based on protein type, the protein engineering market is segmented into monoclonal antibodies, insulin, erythropoietin, interferons, vaccines, colony-stimulating factors, growth hormones, coagulation factors, and other proteins. The monoclonal antibodies segment is estimated to grow at the highest CAGR in this market owing to the increasing demand for monoclonal antibodies for the treatment of cancer, neurological diseases, and infectious diseases.
“Rational protein design segment to grow at the highest CAGR in the protein engineering market, by technology, in 2019”
Based on technology, the protein engineering market is segmented into rational and irrational protein design. The rational protein design segment is estimated to grow at the highest CAGR in this market during the forecast period majorly due to the growing use and continuous upgrades of bioinformatics platforms and software for protein analysis.
Breakdown of primary participants’ profile:
- By Respondent Type: Supply Side: 80%, Demand Side: 20%
- By Designation: C-level Executives: 25%, Directors: 18%, Others: 57%
- By Region: North America: 50%, Europe: 20%, APAC: 20%, RoW: 10%
Reason to access this report:
This report will help market leaders as well as new entrants in the market by providing information on the closest approximations of the revenue numbers for the overall protein engineering market and its sub segments. It will also help stakeholders to understand the competitive landscape, gain more insights to better position their businesses, and plan suitable go-to-market strategies.
Access Free Sample below reports:-
Press Release Distributed by The Express Wire
To view the original version on The Express Wire visit Protein Engineering Market by Technology (Rational Design, Irrational Design), Protein Type (Monoclonal Antibodies, Insulin) – Global Forecast to 2024